Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Gazelle Zerafati"'
Autor:
Bhooma R. Aravamuthan, Toni S. Pearson, Keisuke Ueda, Hanyang Miao, Gazelle Zerafati‐Jahromi, Laura Gilbert, Cynthia Comella, Joel S. Perlmutter
Publikováno v:
Developmental Medicine & Child Neurology.
Autor:
Parith Wongkittichote, Chanseyha Chhay, Gazelle Zerafati-Jahromi, Judith L. Weisenberg, Ali Mian, Laran T. Jensen, Dorothy K. Grange
Publikováno v:
Molecular Genetics and Metabolism. 138:107373
Publikováno v:
Journal of Pediatric Neurology. 11:171-175
The frequency of probable migraine (PM) remains elusive; some of the published literature estimate PM to be at least as prevalent as definite migraine (DM) while others report PM to affect about 5% of the population or less. We conducted a cross sect
Publikováno v:
Journal of Pediatric Neurology. 11:015-021
The phenotypic severity of migraine has rarely been the subject of genetic epidemiological studies. In this study, we conducted a cross sectional survey of high school students using a validated questionnaire which covered the diagnostic features of
Autor:
Elizabeth Min, Meng Zhang, Patrick G. Gallagher, Juliana Xavier-Ferrucio, Elaine Kang, Chad Sanada, Ping-Xia Zhang, Diane S. Krause, Yi-Chien Lu, Gazelle Zerafati, Siying Zou
Publikováno v:
Blood. 128(7)
Bipotent megakaryocyte/erythroid progenitors (MEPs) give rise to progeny limited to the megakaryocyte (Mk) and erythroid (E) lineages. We developed a novel dual-detection functional in vitro colony-forming unit (CFU) assay for single cells that diffe
Publikováno v:
Blood. 120:2310-2310
Abstract 2310 Megakaryocyte/Erythroid Progenitor (MEP) cells are bipotent hematopoietic progenitors that undergo a fate decision to commit to either Megakaryocyte (Mk) or Erythroid (E) lineage. How this biphenotypic fate decision is made is not clear